{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:18:59Z","timestamp":1775755139307,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.acuroe.2026.501925","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:49:15Z","timestamp":1770943755000},"page":"501925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of systemic inflammatory and prognostic \u00edndices in diabetic patients with non-muscle invasive bladder cancer receiving BCG therapy"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-2556","authenticated-orcid":false,"given":"A.","family":"Tun\u00e7ekin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Akta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.acuroe.2026.501925_bib0005","doi-asserted-by":"crossref","first-page":"132.e7","DOI":"10.1016\/j.urolonc.2020.07.017","article-title":"Primary Ta high grade bladder tumors: determination of the risk of progression","volume":"39","author":"Quhal","year":"2021","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.acuroe.2026.501925_bib0010","article-title":"Comparison of Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) and Mitomycin C for the treatment of non-muscle-invasive bladder cancer","volume":"17","author":"Shah","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.acuroe.2026.501925_bib0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12894-018-0404-x","article-title":"Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer","volume":"18","author":"Getzler","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.acuroe.2026.501925_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1486389","article-title":"Prognostic role of prognostic nutritional index in patients with bladder cancer: a systematic review and meta-analysis","volume":"14","author":"Sun","year":"2025","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.acuroe.2026.501925_bib0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/01635581.2024.2374046","article-title":"A multinational, multi-institutional study assessing the impact of diabetes mellitus on the prognosis of patients with non-muscle invasive bladder cancer treated with Bacillus Calmette-Gu\u00e9rin","volume":"76","author":"Abou Chakra","year":"2024","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.acuroe.2026.501925_bib0030","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress, Madrid 2025. ISBN: 978-94-92671-29-5. Available from: https:\/\/uroweb.org\/guidelines."},{"key":"10.1016\/j.acuroe.2026.501925_bib0035","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/OTT.S146990","article-title":"Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ","volume":"10","author":"Cui","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.acuroe.2026.501925_bib0040","article-title":"Prognostic evaluation of non-muscle invasive bladder cancer with P-CRP and its nomogram","volume":"15","author":"Wu","year":"2025","journal-title":"Front Oncol"},{"issue":"13","key":"10.1016\/j.acuroe.2026.501925_bib0045","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3390\/cancers17132189","article-title":"Prognostic value of PLR, SIRI, PIV, SII, and NLR in non-muscle invasive bladder cancer: can inflammatory factors influence pathogenesis and outcomes?","volume":"17","author":"Bizzarri","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.acuroe.2026.501925_bib0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/JIR.S393511","article-title":"Preoperative systemic inflammatory markers as a significant prognostic factor after TURBT in patients with non-muscle-invasive bladder cancer","volume":"16","author":"Ding","year":"2023","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.acuroe.2026.501925_bib0055","article-title":"Prognostic impact of nutritional indicators based on Lasso-Cox regression for non-muscle-invasive bladder cancer","volume":"12","author":"Ye","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.acuroe.2026.501925_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.34172\/ajmb.2499","article-title":"Systemic Immune-Inflammation Index (SII) as prognostic indicator for BCG therapy in bladder cancer: a systematic review and meta-analysis","volume":"12","author":"Nabavizadeh","year":"2024","journal-title":"Avicenna J Med Biochem"},{"key":"10.1016\/j.acuroe.2026.501925_bib0065","article-title":"Inflammation as a key mediator: linking triglyceride-glucose index to prognosis in non-muscle-invasive bladder cancer","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.acuroe.2026.501925_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00345-018-2375-7","article-title":"Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer","volume":"37","author":"Thiel","year":"2019","journal-title":"World J Urol"},{"issue":"Suppl 1","key":"10.1016\/j.acuroe.2026.501925_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000052376","article-title":"Preventing progression and improving survival with BCG maintenance","volume":"37","author":"Lamm","year":"2000","journal-title":"Eur Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:40:17Z","timestamp":1775752817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578626000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2173578626000314"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501925","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of systemic inflammatory and prognostic \u00edndices in diabetic patients with non-muscle invasive bladder cancer receiving BCG therapy","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2026.501925","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501925"}}